We are live on ! Find out more
CM

Capital Management Portfolio holdings

AUM $585M
1-Year Est. Return 5.18%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+5.18%
3 Year Est. Return
+40.88%
5 Year Est. Return
+39.5%
10 Year Est. Return
+202.53%
AUM
$310M
AUM Growth
+$16.2M
Cap. Flow
-$225K
Cap. Flow %
-0.07%
Top 10 Hldgs %
35.23%
Holding
83
New
4
Increased
37
Reduced
25
Closed
2

Top Buys

Rank Stock Value
1
JBSS icon
John B. Sanfilippo & Son
JBSS
+$3.09M
2
AFL icon
Aflac
AFL
+$2.83M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$2.58M
4
V icon
Visa
V
+$2.12M
5
ITW icon
Illinois Tool Works
ITW
+$1.89M

Sector Composition

Rank Sector Weight
1 Financials 32.32%
2 Technology 15.36%
3 Energy 7.59%
4 Healthcare 6.94%
5 Real Estate 6.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AJG icon
26
Arthur J. Gallagher & Co
AJG
$68.2B
$5.83M 1.88%
125,025
+56,623
+83% +$2.58M
PRAA icon
27
PRA Group
PRAA
$688M
$5.53M 1.79%
92,945
+5,430
+6% +$310K
CVX icon
28
Chevron
CVX
$374B
$5.12M 1.65%
39,218
-22,934
-37% -$2.85M
JBSS icon
29
John B. Sanfilippo & Son
JBSS
$989M
$4.85M 1.57%
183,130
+123,955
+209% +$3.09M
AON icon
30
Aon
AON
$81.4B
$4.71M 1.52%
52,335
+1,835
+4% +$159K
ESRX
31
DELISTED
Express Scripts Holding Company
ESRX
$4.58M 1.48%
66,030
+395
+0.6% +$27.8K
VZ icon
32
Verizon
VZ
$201B
$4.51M 1.46%
92,191
+4,314
+5% +$209K
EW icon
33
Edwards Lifesciences
EW
$48.2B
$3.81M 1.23%
265,950
-73,440
-22% -$996K
WU icon
34
Western Union
WU
$2.58B
$3.52M 1.14%
202,913
+1,200
+0.6% +$19.4K
QCOR
35
DELISTED
QUESTCOR PHARMA INC
QCOR
$3.27M 1.06%
35,343
-143,022
-80% -$12.2M
SIRO
36
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
$2.46M 0.79%
29,815
+10
+0% +$761
PNC icon
37
PNC Financial Services
PNC
$100B
$2.41M 0.78%
27,077
+460
+2% +$39.3K
PAYX icon
38
Paychex
PAYX
$42.3B
$2.37M 0.76%
56,990
+134
+0.2% +$5.51K
CHRW icon
39
C.H. Robinson
CHRW
$20B
$2.35M 0.76%
36,837
-20
-0.1% -$1.18K
ANIK icon
40
Anika Therapeutics
ANIK
$202M
$2.31M 0.74%
49,765
+585
+1% +$26K
VCSH icon
41
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$2.06M 0.67%
25,698
+520
+2% +$41.7K
URBN icon
42
Urban Outfitters
URBN
$6.44B
$1.92M 0.62%
56,770
+1,270
+2% +$44.5K
RMCF icon
43
Rocky Mountain Chocolate Factory
RMCF
$8.29M
$1.91M 0.62%
144,572
+6,960
+5% +$82.5K
VAR
44
DELISTED
Varian Medical Systems, Inc.
VAR
$1.9M 0.61%
26,008
-30,864
-54% -$2.22M
XOM icon
45
ExxonMobil
XOM
$634B
$1.74M 0.56%
17,276
-380
-2% -$38.3K
JNJ icon
46
Johnson & Johnson
JNJ
$643B
$1.68M 0.54%
16,100
-525
-3% -$53.1K
FRF
47
DELISTED
FORTEGRA FINL CORP COM STK (DE)
FRF
$1.25M 0.4%
163,928
+2,400
+1% +$16.9K
ACU icon
48
Acme United Corp
ACU
$227M
$1.22M 0.39%
72,914
+32,699
+81% +$549K
ALB icon
49
Albemarle
ALB
$13.3B
$1.22M 0.39%
+17,000
New +$1.17M
PM icon
50
Philip Morris
PM
$312B
$1.14M 0.37%
13,560

Similar funds

Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Capital Management held 83 positions worth $310M, up 5.5% from $293M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Capital Management's Q2 2014 filing shows 4 new, 37 increased, 25 reduced and 2 closed positions. Its largest new stake was Albemarle: 17,000 shares worth $1.22M. The largest sale was QUESTCOR PHARMA INC, an estimated $12.2M.

By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 30% a quarter earlier, followed by Technology and Energy.

  • Capital Management's largest Q2 2014 buy was Albemarle: 17,000 shares worth $1.22M.
  • Capital Management added most to John B. Sanfilippo & Son in Q2 2014, an estimated $3.09M increase.
  • Capital Management's biggest Q2 2014 reduction was QUESTCOR PHARMA INC, cutting an estimated $12.2M.
  • Capital Management fully exited Analog Devices in Q2 2014, selling an estimated $3.34M.
  • Capital Management's ten largest holdings make up 35% of its $310M portfolio in Q2 2014.
  • Capital Management opened 4 new positions and closed 2 in Q2 2014.
  • Capital Management's portfolio value rose 5.5% quarter-over-quarter to $310M.

Based on Capital Management's 13F filing for Q2 2014, filed 31 Jul 2014.